Cadence Capital Management’s NEOPHOTONICS CORP NPTN Stock Holding History

Cadence Capital Management’s Portfolio NPTN Stock Details NPTN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	$274K	Sell	44,999 -147,527	-77%	-$1.13M	0.07%	246
2020 Q2	$1.71M	Buy	192,526 +8,036	+4%	+$69.3K	0.25%	111
2020 Q1	$1.34M	Buy	+184,490	New	+$1.37M	0.23%	126
2016 Q3	–	Sell	-101,450	Closed	-$967K	–	667
2016 Q2	$967K	Buy	101,450 +65,250	+180%	+$710K	0.07%	296
2016 Q1	$508K	Buy	+36,200	New	+$375K	0.04%	479

Other funds holding NPTN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

PCMI

Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

AIC

AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

MCM

Masters Capital Management Atlanta, Georgia $3.03B AUM 57.21% 1-Year Est. Return

Cadence Capital Management's NPTN Position: Q3 2020 in Review

Cadence Capital Management reduced its NEOPHOTONICS CORP (NPTN) stake by 77% in Q3 2020, selling an estimated $1.13M and leaving 44,999 shares worth $274K. The position accounts for 0.07% of the portfolio, ranked #246.

Cadence Capital Management first reported a position in NPTN in Q1 2016 and has held it in 5 quarters since. The position peaked at $1.71M in Q2 2020. 140 funds tracked by Wall St. Rank hold NPTN as of Q3 2020.

Cadence Capital Management held 44,999 shares of NEOPHOTONICS CORP worth $274K as of Q3 2020.
Cadence Capital Management sold 147,527 NEOPHOTONICS CORP shares in Q3 2020, an estimated $1.13M.
NEOPHOTONICS CORP made up 0.07% of Cadence Capital Management's portfolio in Q3 2020, its #246 holding.
Cadence Capital Management first reported a position in NEOPHOTONICS CORP in Q1 2016 and has held it in 5 quarters since.
Cadence Capital Management's NEOPHOTONICS CORP position peaked at $1.71M in Q2 2020.
140 funds tracked by Wall St. Rank held NEOPHOTONICS CORP as of Q3 2020.

Based on Cadence Capital Management's 13F filing for Q3 2020, filed 16 Oct 2020.